539470 — Shree Ganesh Bio-Tech (India) Income Statement
0.000.00%
Last trade - 00:00
- IN₹466.39m
- IN₹465.71m
- IN₹624.55m
- 43
- 57
- 70
- 61
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 58.7 | 24.7 | 172 | 726 | 625 |
Cost of Revenue | |||||
Gross Profit | 25.1 | 8.98 | 8.84 | 38.1 | 28.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 40.8 | 22.4 | 168 | 692 | 603 |
Operating Profit | 17.9 | 2.36 | 4.28 | 34.5 | 21.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 17.9 | 2.36 | 4.28 | 35 | 27.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 17.9 | 2.36 | 3.17 | 25.3 | 20.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 17.9 | 2.36 | 3.17 | 25.3 | 20.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17.9 | 2.36 | 3.17 | 25.3 | 20.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.045 | 0.006 | 0.014 | 0.066 | 0.051 |